Sign in

NCT04219800Completed

Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity. These findings open up for a new focus in T2DM treatment but conclusive evidence is missing as studies have been short-term trials, mainly conducted in laboratory environments. Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks. The overarching purpose of the project is to evaluate the effects of an intervention aimed to reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that the intervention will lead to (1) Activity changes - reduced sitting time and/or increased number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved health-related quality of life, reduced cardiometabolic risk, less sick leave, less medication, less musculoskeletal problems (secondary outcome measures)

Status (registry)
Completed
Study type
Interventional
Enrollment
46 (actual)
First submitted
2 Jan 2020
Start date
8 Dec 2020
Primary completion date
30 Dec 2023
Lead sponsor
Umeå University
NCT number
NCT04219800

What you commit to

  • Study type: Interventional
  • Participants enrolled: 46
  • From 8 Dec 2020 to the primary completion date, 30 Dec 2023
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe disease or for other reason unable to follow the study protocol

Other

  • Pregnancy
  • Regular vigorous intensity exercise

Who the study is looking for

  • Type 2 Diabetes Melltitus
  • 40-64 years
  • HbA1c 48-100 mmol/mol
  • BMI ≥ 25 kg/m2
  • Working at least 75% of full-time in a mainly seated job.

Age in the registry: 40 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hallsbergs hälsocentral
Coordinator of this site? Confirm its status
HallsbergSwedenUnknown status
Kärna Vårdcentral
Coordinator of this site? Confirm its status
LinköpingSwedenUnknown status
Björkskatans Hälsocentral
Coordinator of this site? Confirm its status
LuleåSwedenUnknown status
Clinical Research Centre
Coordinator of this site? Confirm its status
ÖstersundSwedenUnknown status
Torsviks Vårdcentral
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status
Clinical Research Centre
Coordinator of this site? Confirm its status
UmeåSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.